Does Medicare Cover Ozempic?

Ozempic questions top Medicare helpline call volumes in 2026 because the rules are counterintuitive: same drug, different diagnosis, entirely different coverage outcome. These answers cover every variation people search for — starting with the most important one.

• 1
  Does Medicare cover Ozempic? Yes — for Type 2 diabetes · Yes — for cardiovascular risk reduction with heart disease · No — for weight loss alone (until July bridge program, which covers Wegovy, not Ozempic) · Requires Part D enrollment + prior authorization + matching diagnosis

  Medicare Part D covers Ozempic (semaglutide) when your doctor prescribes it for one of its FDA-approved indications — Type 2 diabetes management or reducing cardiovascular events in adults with established heart disease who are overweight or obese. Coverage is not automatic: your plan must include Ozempic on its formulary, prior authorization is required at most plans, and the prescription documentation must explicitly state the qualifying diagnosis. If any of those three pieces are missing, the claim is denied — not because you do not qualify, but because the paperwork trail is incomplete. The fix is almost always updating the clinical documentation from your doctor, not filing an appeal from scratch.
• 2
  Does Medicare cover Ozempic for weight loss? No — Ozempic is not covered for weight loss alone under any Medicare plan · The weight-loss indication is FDA-approved under Wegovy (same drug, different brand) · Wegovy for weight loss enters Medicare via the July bridge program at $50/month · Ozempic for weight loss does not qualify even under the bridge program

  This is the question that catches the most people off guard. Ozempic and Wegovy contain identical active ingredients at different doses — but they carry separate FDA approvals, separate brand names, and completely separate Medicare coverage rules. Ozempic is approved for diabetes; Wegovy is approved for weight loss and cardiovascular protection. Federal law has prohibited Medicare Part D from covering weight-loss drugs since the program was created in 2003. That restriction is not being lifted for Ozempic specifically — it is being lifted, partially and temporarily, for the weight-management indication, which belongs to Wegovy and Zepbound. If your doctor writes “Ozempic for weight loss” on a prescription, that combination is not covered under any current or upcoming Medicare program.
• 3
  Does Medicare cover Ozempic for weight loss for seniors? Not under the Ozempic brand · Seniors seeking GLP-1 coverage for weight management should ask their doctor about Wegovy — same molecule, covered under the July bridge at $50/month · Must be enrolled in a participating Part D plan · BMI ≥30, or ≥27 with a weight-related condition, typically required

  For a senior who wants the clinical benefits of semaglutide for weight management, the path runs through Wegovy rather than Ozempic. The distinction is purely administrative — the active ingredient is identical — but Medicare processes coverage based on brand name tied to FDA-approved indication. The good news: your doctor can prescribe Wegovy for weight management, you can enroll in or confirm your Part D plan participates in the bridge, and the copay is a flat $50/month. The important caveat is that not every Part D plan has opted into the bridge program — you must call your plan’s member services line and ask specifically before July 1.
• 4
  Does Medicare cover Ozempic for diabetes? Yes — this is the clearest-cut coverage path · Over 90% of Part D plans include Ozempic or a GLP-1 equivalent on formulary for Type 2 diabetes · Prior authorization required at most plans · Some plans require step therapy — trying metformin or other agents first · 17.7 million Medicare beneficiaries (26%+) have Type 2 diabetes and may already qualify

  Type 2 diabetes is the original and most straightforward qualifying condition for Ozempic under Medicare. The FDA approved it for this indication in 2017, and Part D plans have covered it for years. The friction points are practical rather than policy-based: prior authorization paperwork takes days to process, step therapy requirements delay access at some plans, and formulary tier placement varies widely enough to produce copay differences of $50–$200/month for the same drug on different plans. If your plan requires step therapy, your doctor should document why other diabetes agents are not appropriate for you — particularly if you have tried metformin and had issues with it. That documentation is the key to bypassing the step-therapy queue when it is clinically justified.
• 5
  Does Medicare cover Ozempic for Type 2 diabetes? Yes — Part D coverage applies · Placement is typically on a specialty or non-preferred brand tier · Out-of-pocket cost varies by plan: $0–$200+/month depending on tier and deductible status · 2026 Part D out-of-pocket cap: $2,100/year total for covered drugs · Medicare Extra Help (LIS) can reduce copays to $11.20 or less per fill for income-qualifying seniors

  The tier placement question matters more than most beneficiaries realize. Ozempic on a preferred specialty tier can cost $50–$100/month out of pocket; on a non-preferred tier at the same plan it might be $150–$250/month before hitting the $2,100 annual cap. The new 2026 out-of-pocket cap is meaningful protection — once you hit $2,100 in covered drug spending, your plan pays 100% for the rest of the year. For a senior with no other expensive medications, that cap may be reached mid-year on Ozempic alone. The Medicare Extra Help (Low Income Subsidy) program reduces specialty-tier copays to as low as $11.20/month for qualifying beneficiaries — a program that remains dramatically underutilized among seniors who meet the income threshold.
• 6
  Does Medicare cover Ozempic for prediabetes? No — prediabetes is not a qualifying diagnosis for Ozempic under Medicare Part D · The coverage threshold requires a formal Type 2 diabetes diagnosis · Prediabetes range: A1C 5.7–6.4% · Type 2 diabetes threshold: A1C ≥6.5% · Medicare Part B covers the Diabetes Prevention Program for prediabetes — a lifestyle coaching program (not a drug)

  If you are in the prediabetes range and your doctor wants to prescribe Ozempic, Medicare Part D will deny that claim. The qualifying event is a formal Type 2 diabetes diagnosis — which the American Diabetes Association defines as an A1C at or above 6.5%, a fasting glucose at or above 126 mg/dL, or a two-hour glucose at or above 200 mg/dL during an oral glucose tolerance test. If your numbers are borderline, a detailed conversation with your doctor about whether a formal Type 2 diabetes diagnosis is clinically accurate — not just convenient — is worth having. Medicare Part B does separately cover the National Diabetes Prevention Program (DPP) for beneficiaries with prediabetes — a year-long structured lifestyle intervention with demonstrated effectiveness at delaying or preventing progression.
• 7
  Does Medicare cover Ozempic for heart disease? Yes — with conditions · Ozempic is FDA-approved to reduce cardiovascular events (heart attack, stroke) in adults with Type 2 diabetes AND established heart disease · Wegovy (same active ingredient) covers cardiovascular risk reduction in adults with heart disease who are overweight/obese, even without diabetes · Part D plan formulary and prior authorization still apply

  The cardiovascular indication is one of the most overlooked coverage pathways for Medicare beneficiaries. If you have a documented history of heart attack, stroke, or peripheral arterial disease — and you have Type 2 diabetes — Ozempic is approved for cardiovascular risk reduction in that specific combination, and Part D plans may cover it under that indication. For beneficiaries with heart disease and obesity but without diabetes, Wegovy carries the cardiovascular protection indication without requiring a diabetes diagnosis. This pathway often allows access to semaglutide for people who have been told they “do not qualify” because they are using it for weight management — if the prescription is written for the cardiovascular indication instead, the coverage rules change entirely.
• 8
  Does Medicare cover Ozempic for obesity? No — obesity alone does not make Ozempic coverable under Medicare · The weight-loss/obesity indication belongs to Wegovy, not Ozempic · Wegovy for obesity: covered under July bridge program at $50/month for qualifying Part D enrollees · Without a qualifying condition (diabetes, heart disease), Wegovy is the appropriate brand to discuss with your doctor

  Obesity as a standalone diagnosis does not make Ozempic coverable under any current or upcoming Medicare program. The federal exclusion on weight-loss drugs has been in place since 2003 and applies specifically to the weight-loss indication. What is opening up through the bridge and BALANCE programs is coverage for the weight-management indication — which belongs to Wegovy. Seniors with obesity who want semaglutide should have a direct conversation with their doctor about Wegovy rather than Ozempic, because the coverage pathway, the FDA approval, and the Medicare program that covers it are all tied to the Wegovy brand for this use case.
• 9
  Is Medicare going to cover Ozempic in the future? Ozempic is already covered for diabetes and cardiovascular disease · The bigger upcoming change is price: CMS-negotiated price of ~$274/month (from ~$997) takes effect January 2027 · For weight-loss coverage under Medicare, Wegovy is the relevant brand — not Ozempic · BALANCE Model adds broader GLP-1 weight-management coverage starting January 2027

  The most consequential near-term change for Medicare beneficiaries on Ozempic is not about coverage eligibility — it is about cost. Ozempic, Rybelsus, and Wegovy were selected for Medicare drug price negotiation under the Inflation Reduction Act, and CMS finalized a negotiated price of approximately $274/month effective January 1, 2027. AARP research projects this will cut average out-of-pocket costs for beneficiaries currently covered for Ozempic by roughly 50% from 2025 levels. Combined with the 2026 Part D out-of-pocket cap of $2,100/year, the financial trajectory for covered beneficiaries is meaningfully improving over the next 18 months.

Coverage also subject to plan-specific formulary, prior authorization, and step therapy requirements. Always verify with your Part D plan. T2D = Type 2 Diabetes. CVD = established cardiovascular disease. OSA = obstructive sleep apnea.

The $25 NovoCare savings card is not available to Medicare enrollees — federal law prohibits manufacturer coupons for government insurance. Here is what actually works for seniors.

These buttons find free Medicare counseling offices, doctors who prescribe Ozempic, and prescription assistance programs near your location.